Association of Taq 1B CETP polymorphism with insulin and HOMA levels in the population of the Canary Islands

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 1, 2011, Pages 18-24

  Lopez Rios L ^a,b   Perez Jimenez P ^b   Martinez Quintana E ^c   Rodriguez Gonzalez G ^b   Diaz Chico B N ^b   Novoa F J ^a,b   Serra Majem, L ^b   Chirino, R ^b  

^a Servicio de Endocrinología   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

CETP; HOMA; Insulin; Taq 1B polymorphism

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD; COHORT ANALYSIS; FEMALE; GENETIC POLYMORPHISM; GENETICS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; NUTRITION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPAIN;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; BLOOD GLUCOSE; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; COHORT STUDIES; DNA; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; NUTRITION SURVEYS; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPAIN; YOUNG ADULT;

EID: 78751630656     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.06.009     Document Type: Article

References (34)

1. Barter P.J., Hopkins G.J., Calvert G.D. Transfers and exchanges of esterified cholesterol between plasma lipoproteins. Biochem J 1982 Oct 15, 208(1):1-7.
2. Tall A.R. Plasma cholesteryl ester transfer protein. J Lipid Res 1993 Aug, 34(8):1255-1274.
3. Lagrost L., Gandjini H., Athias A., Guyard-Dangremont V., Lallemant C., Gambert P. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler Thromb 1993 Jun, 13(6):815-825.
4. Barter P.J., Brewer H.B., Chapman M.J., Hennekens C.H., Rader D.J., Tall A.R. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003 Feb 1, 23(2):160-167.
5. Inazu A., Brown M.L., Hesler C.B., Agellon L.B., Koizumi J., Takata K., et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990 Nov 1, 323(18):1234-1238.
6. Ikewaki K., Rader D.J., Sakamoto T., Nishiwaki M., Wakimoto N., Schaefer J.R., et al. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest 1993 Oct, 92(4):1650-1658.
7. Yamashita S., Matsuzawa Y., Okazaki M., Kako H., Yasugi T., Akioka H., et al. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. Atherosclerosis 1988 Mar, 70(1-2):7-12.
8. Kondo I., Berg K., Drayna D., Lawn R. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 1989 Jan, 35(1):49-56.
9. Wu J.H., Lee Y.T., Hsu H.C., Hsieh L.L. Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan. Atherosclerosis 2001 Dec, 159(2):451-458.
10. Arai H., Yamamoto A., Matsuzawa Y., Saito Y., Yamada N., Oikawa S., et al. Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J Atheroscler Thromb 2005, 12(5):240-250.
11. Corella D., Saiz C., Guillen M., Portoles O., Mulet F., Gonzalez J.I., et al. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Atherosclerosis 2000 Oct, 152(2):367-376.
12. Hodoglugil U., Williamson D.W., Huang Y., Mahley R.W. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks. Clin Genet 2005 Aug, 68(2):118-127.
13. Noone E., Roche H.M., Black I., Tully A.M., Gibney M.J. Effect of postprandial lipaemia and Taq 1B polymorphism of the cholesteryl ester transfer protein (CETP) gene on CETP mass, activity, associated lipoproteins and plasma lipids. Br J Nutr 2000 Aug, 84(2):203-209.
14. Boekholdt S.M., Kuivenhoven J.A., Hovingh G.K., Jukema J.W., Kastelein J.J., van Tol A. CETP gene variation: relation to lipid parameters and cardiovascular risk. Curr Opin Lipidol 2004 Aug, 15(4):393-398.
15. Mukherjee M., Shetty K.R. Variations in high-density lipoprotein cholesterol in relation to physical activity and Taq 1B polymorphism of the cholesteryl ester transfer protein gene. Clin Genet 2004 May, 65(5):412-418.
16. Kuivenhoven J.A., de Knijff P., Boer J.M., Smalheer H.A., Botma G.J., Seidell J.C., et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 1997 Mar, 17(3):560-568.
17. Ordovas J.M., Cupples L.A., Corella D., Otvos J.D., Osgood D., Martinez A., et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham Study. Arterioscler Thromb Vasc Biol 2000 May, 20(5):1323-1329.
18. Sandhofer A., Tatarczyk T., Laimer M., Ritsch A., Kaser S., Paulweber B., et al. The Taq 1B-variant in the cholesteryl ester-transfer protein gene and the risk of metabolic syndrome. Obesity (Silver Spring) 2008 Apr, 16(4):919-922.
19. Serra-Majem L.A.A., Ribas L. Encuesta Nutricional de Canarias. Hábitos alimentarios y consumo de alimentos 1999, Vol. 1. on behalf of the ENCA Research Team, Servicio canario de Salud, Santa Cruz de Tenerife, Available from:. http://www.gobiernodecanarias.org/sanidad/scs/1/plansalud/enca/ppal_enca.htm.
20. Mellitus TECotDacoD Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003 Jan, 26(Suppl. 1):S5-S20.
21. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 Jun, 18(6):499-502.
22. Miltiadous G., Hatzivassiliou M., Liberopoulos E., Bairaktari E., Tselepis A., Cariolou M., et al. Gene polymorphisms affecting HDL-cholesterol levels in the normolipidemic population. Nutr Metab Cardiovasc Dis 2005 Jun, 15(3):219-224.
23. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 Jul, 28(7):412-419.
24. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006 May, 23(5):469-480.
25. Strazzullo P., Barbato A., Siani A., Cappuccio F.P., Versiero M., Schiattarella P., et al. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population. Metabolism 2008 Mar, 57(3):355-361.
26. Thompson J.F., Durham L.K., Lira M.E., Shear C., Milos P.M. CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis 2005 Jul, 181(1):45-53.
27. MacLean P.S., Bower J.F., Vadlamudi S., Green T., Barakat H.A. Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: a comparison of African and White Americans. Obes Res 2000 Jan, 8(1):62-70.
28. Hayashibe H., Asayama K., Nakane T., Uchida N., Kawada Y., Nakazawa S. Increased plasma cholesteryl ester transfer activity in obese children. Atherosclerosis 1997 Feb 28, 129(1):53-58.
29. Dullaart R.P., Sluiter W.J., Dikkeschei L.D., Hoogenberg K., Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994 Mar, 24(3):188-194.
30. Sutherland W.H., Walker R.J., Lewis-Barned N.J., Pratt H., Tillmann H.C., Tillman H.C. The effect of acute hyperinsulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin-dependent diabetes mellitus and healthy subjects. Metabolism 1994 Nov, 43(11):1362-1366.
31. Arii K., Suehiro T., Yamamoto M., Ito H., Hashimoto K. Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid. Metabolism 1997 Oct, 46(10):1166-1170.
32. Kaser S., Foger B., Ebenbichler C.F., Kirchmair R., Gander R., Ritsch A., et al. Influence of leptin and insulin on lipid transfer proteins in human hepatoma cell line, HepG2. Int J Obes Relat Metab Disord 2001 Nov, 25(11):1633-1639.
33. Ginsberg H.N., Zhang Y.L., Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 2005 May-Jun, 36(3):232-240.
34. Reaven G.M. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med 2005 Dec, 47(4):201-210.